Business News • PR NewsWire • New Data Demonstrates Investigational Triple Antihypertensive Combination Therapy Produces Superior Blood Pressure Reductions Compared to Corresponding Dual Treatments

New Data Demonstrates Investigational Triple Antihypertensive Combination Therapy Produces Superior Blood Pressure Reductions Compared to Corresponding Dual Treatments

New Data Demonstrates Investigational Triple Antihypertensive Combination Therapy Produces Superior Blood Pressure Reductions Compared to Corresponding Dual Treatments

PARSIPPANY, N.J., May 1 /PRNewswire/ -- Results of a new study found that the investigational triple combination therapy of olmesartan medoxomil (OM), amlodipine besylate (AML), and hydrochlorothiazide (HCTZ) demonstrated significantly greater mean reductions at week 12 in blood pressure (37.1/21.8

View More : http://www.prnewswire.com/news-releases/new-data-demonstrates-investigational-triple-antihypertensive-combination-therap...

Releted News by prnewswire

260 Elephants on Parade in London This Bank Holiday Monday

Call for Nominations Open Now for the 2010 Awards for Excellence in Inter-American Public Health

Landrieu Sends Letter to SBA in Support of Small Business Owners Impacted By Oil Spill Disaster